1[1] Fuqua SAW,Fitzgerald SD, Chamness GC, et al.Variant human breast tumor estrogen receptor with constitutive transcriptional activity[J].Cancer Res,1991,51:105.
2[2] Rio MC,Bellocq JP, Daniel JY, et al.Breast cancer-associated pS2 protein:synthesis and secretion by normal stomach mucosa[J].Science,1988,241:705.
3[3] Diez Gibert 0,Machuca Z,Sebastian MA, et al. Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors. Med Clin Barc,1996,107(3):90.
4[4] Kawabata K, Watanabe K, Ozaki S. Expression of pS2-protein in breast cancer[J].Rinsho Byori,1996,44(7):647.
5[5] Racca S, Conti G, Pietribiasi, et al. Correlation between pS2 protein positivity, steroid receptor status and other progrostic factors in breast cancer[J].Int J Biol Markers,1995,10:87.
6[6] Gion M, Mione R, Pappagallo Gl, et al. pS2 in breast cancer alternative or complementary tools of steroid receptor status? Evaluation of 446 cases.[J].Br J Cancer,1993,68:374.
7[7] Yano M, Naito Z, Tanaka S, et al. Expression and roles of heat shock proteins in human breast cancer[J].Jpn J Cancer Res,1996,87:908.
8[8] Ciocca DR, Oesterreich S, Chamness GC,et al.Biological and clinical implications of heat shock protein 27,000(Hsp27):a review[J].J Natl Cancer Inst,1993,85:1558.
9[9] Dunn DK, Whelan RD, Hill B, et al.Relationship of HSP27 and oestrogen teceptor in hormone sensitive and insensitive cell lines[J].J Steroid Biochem Mol Biol,1993,46:469.
10[10] Love S, King RJ. A 27 Kda heat shock protein that has anomalous prognostic powers in early and advanced breast cancer[J].Br J Cancer, 1994,69:743.
